Veracyte Inc. | C2i Genomics Email Format

Biotechnology ResearchNew York, United States11-50 Employees

Veracyte Inc., based in New York, New York, operates in the biotechnology research sector and now includes C2i Genomics in its corporate structure. The combined organization focuses on cancer diagnostics and genomics research, supported by a small team. It occupies a position within the broader field of cancer diagnostics, developing tools intended to inform clinical decision-making. It centers its product development on tests and related tools designed to support treatment decisions in cancer care. In 2026, the company announced a breast cancer test intended to identify patients who may not require chemotherapy, presented at ASCO. It also reported the US launch of Prosigna LDT following clinical trial data presented at ASCO.

Sign up for free to view info

Company overview Employee directory